Article cité par

La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).

Article cité :

Drug Abuse Monitoring: Which Pharmacoepidemiological Resources at the European Level?

Maryse Lapeyre-Mestre, Mathilde Dupui

Therapie, 70 2 (2015) 157-165

Publié en ligne : 2015-04-09

DOI: https://doi.org/10.2515/therapie/2015010

Citations de cet article :

Smartphone swabs as an emerging tool for toxicology testing: a proof-of-concept study in a nightclub

Théo Willeman, Justine Grunwald, Marc Manceau, Frédéric Lapierre, Lila Krebs-Drouot, Coralie Boudin, Virginie Scolan, Hélène Eysseric-Guerin, Françoise Stanke-Labesque and Bruno Revol
Clinical Chemistry and Laboratory Medicine (CCLM) 62 (9) 1845 (2024)
https://doi.org/10.1515/cclm-2024-0242

Misuse of psychoactive medicines and its consequences in the European Union – a scoping review

Ana Carmona Araújo, Rita João Casal, João Goulão and Ana Paula Martins
Journal of Substance Use 29 (4) 629 (2024)
https://doi.org/10.1080/14659891.2023.2213325

Case Report: the Comorbidity of Pregabalin-Use Disorder and Post-Traumatic Stress Disorder: Clinical and Pharmacological Issues

Gaël Galliot, Camille Ponté, Laurent Schmitt, Yann Hakimi, Sami Sergent, Maryse Lapeyre-Mestre and Juliette Salles
International Journal of Mental Health and Addiction 20 (1) 152 (2022)
https://doi.org/10.1007/s11469-020-00347-4

Early Detection of Prescription Drug Abuse Using Doctor Shopping Monitoring From Claims Databases: Illustration From the Experience of the French Addictovigilance Network

Thomas Soeiro, Clémence Lacroix, Vincent Pradel, Maryse Lapeyre-Mestre and Joëlle Micallef
Frontiers in Psychiatry 12 (2021)
https://doi.org/10.3389/fpsyt.2021.640120

Innovative approaches in CNS clinical drug development: Quantitative systems pharmacology

Clémence Lacroix, Thomas Soeiro, Marguerite Le Marois, et al.
Therapies 76 (2) 111 (2021)
https://doi.org/10.1016/j.therap.2020.12.007

Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance

Marine Tambon, Camille Ponté, Emilie Jouanjus, et al.
Frontiers in Psychiatry 12 (2021)
https://doi.org/10.3389/fpsyt.2021.639780

Pregabalin Abuse in Combination With Other Drugs: Monitoring Among Methadone Patients

Massimo Lancia, Angela Gambelunghe, Alessio Gili, et al.
Frontiers in Psychiatry 10 (2020)
https://doi.org/10.3389/fpsyt.2019.01022

Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution

Mathilde Dupui, Joëlle Micallef and Maryse Lapeyre-Mestre
Therapies 74 (2) 307 (2019)
https://doi.org/10.1016/j.therap.2018.09.078

Du médicament psychoactif à l’addictovigilance dans le Code de la santé publique en France (1990–2017)

Marie Baumevieille, Joëlle Perri-Plandé, Ghada Miremont-Salamé, Amélie Daveluy and Françoise Haramburu
Therapies 74 (3) 375 (2019)
https://doi.org/10.1016/j.therap.2018.07.007

Patterns of gabapentin and pregabalin use and misuse: Results of a population‐based cohort study in France

Damien Driot, Emilie Jouanjus, Stéphane Oustric, Julie Dupouy and Maryse Lapeyre‐Mestre
British Journal of Clinical Pharmacology (2019)
https://doi.org/10.1111/bcp.13892